BCR and neoplasm: Human leukocyte antigen (HLA), a vast number of unique T- and B-cell receptor genes (TCR and BCR), and somatic alterations in tumor cell genomes allow for differentiation between self and non-self (tumor) antigens via neoantigen (NAG) presentation, which contributes to positive and negative immune reactions related to cancer3–6.